The isoflavones market is estimated at USD 1.1 billion in 2019 and is projected to reach USD 1.5 billion by 2025, at a CAGR of 4.7% during the forecast period. Growth in this market is mainly driven by the increasing incidences of chronic diseases, rising prevalence of cancer, technological advancements in the manufacturing of isoflavones, and the rapidly increasing geriatric population. However, stringent regulatory requirements and unfavorable drug price control policies across various countries are significant factors that are expected to restrain the growth of this market to a certain extent.
By source, the red clover segment is projected to be the fastest-growing segment within the global isoflavones industry during the forecast period. The full applications of red clover in applications such as food & beverages, pharmaceuticals, and nutraceuticals are expected to drive the demand. Also, it is used in tea blends due to its nutritional properties. In the pharmaceutical industry, red clover is used as it reduces hypertension, prevents infections, and eases menstruation and menopause symptoms in women. In the cosmetics industry, it is used for the production of facial creams, body lotions, hair oil, and other products.
Based on the application, the pharmaceutical segment is projected to be the most extensive application during the forecast period. This is due to factors such as the increasing incidences of cancer, cardiovascular diseases, and growth in funding for cancer research (for the development of novel cancer drugs and therapies).
Based on form, The powder segment dominated the isoflavones market in 2018 and is projected to continue its dominance during the forecast period. Factors such as ease in handling and usage of isoflavone powder in a wide range of pharmaceutical and nutraceutical applications boost the market demand.
To know about the assumptions considered for the study, download PDF brochure
North America is the fastest and largest growing market for isoflavones; it is projected to record the highest CAGR during the forecast period. Factor propelling the growth of isoflavones in the region is rising obesity, which is a major concern among the youth, which is directing consumers’ focus toward a healthy lifestyle, thereby promoting their overall health and wellness.
Key players in this market include Cargill (Germany), ADM (US), BASF (Germany), DSM (Netherlands), International Flavors and Fragrances (Frutarom) (US), Shanghai Freemen (US), Nexira Inc. (France), Bio-gen Extracts, Sikko Industries, SK Bioland (South Korea), BioMax (India), Avestia Pharma (India), NutraScience Labs (US), Tradichem S.L. (Spain), Nutra Green Biotechnology (China), Herbo Nutra (India), FutureCeuticals Inc. (US), Bio-gen Extracts (US), Xena Bio Herbals Pvt. Ltd. (India), Sikko Industries (India), Biomax (India), and Lactonova (India).
Cargill is amongst the largest suppliers of ingredients, resources, and expertise, which aids it in the development of food & beverage products across the globe. It provides its services through four major business segments, namely, animal nutrition & protein, food ingredients & applications, origination & processing, and industrial & financial services. Cargill Health and Food Technologies, a subsidiary of Cargill, is a leading developer, processor, and marketer of science-based, health-promoting ingredients for food and dietary supplement industries and provides isoflavones worldwide. Cargill provides isoflavones product under the brand name Advanta soy for the application in dietary supplement.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Archer Daniels Midland (ADM) is among the key players in the isoflavones marke. The company produces food & beverage ingredients, feed ingredients, industrial ingredients, biofuels, and naturally derived alternatives to industrial chemicals. The company focuses on scaling up operations to meet the growing demand for isoflavones in the current market scenario. ADM also focuses on inorganic growth strategies through ex-pansion to meet the increasing demand for isoflavones. As of January 2018, ADM opened an innovation center in Singapore. This center would facilitate ingredient development and the application of food, feed, industrial, and energy products. The company is keen on improving its current production capacity to meet the increasing demand from consumers.
